As the development of vaccines or any drug will take time, research on Sars-CoV-2 neutralising antibodies is gaining ground to fill an unmet demand in therapy
from Latest News https://ift.tt/3cANjXw
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Covid-19 fight: Indian companies join race to develop blood products
0 comments: